LM Pay (Y00.BE) Stock Price

LM Pay SA generates revenue through its MediRaty financing and installment payment system, which targets consumers seeking medical and veterinary services. The company partners with clinics offering specialized treatments like dentistry, plastic surgery, and orthopedics, enabling patients to finance procedures such as dental implants, liposuction, and breast augmentation through MediRaty or MediPay programs. These services are available at both partner facilities and non-partner locations, with financing options tailored to cover costs in fields including ophthalmology, gynecology, and veterinary care. The firm monetizes by facilitating installment payments for medical and veterinary expenses without direct ownership of the services provided. The primary customers are individuals requiring medical treatments or veterinary services, with the company focusing on high-cost procedures such as orthodontic braces, implant prosthetics, and aesthetic surgeries. LM Pay SA’s revenue model relies on transaction fees from clinics and service providers that utilize its financing platforms, rather than direct consumer payments. This approach allows the company to serve a broad segment of consumers seeking accessible financing for healthcare without bearing the risk of the medical services themselves. MediRaty and MediPay programs are designed to integrate seamlessly with clinics' operations, providing patients with flexible payment options. The company’s revenue streams are derived from the financial institutions or healthcare providers that adopt its systems, as these partners pay for access to the financing infrastructure. This business model ensures consistent income from established healthcare and veterinary service providers across Poland, supporting the expansion of affordable healthcare financing options for end-users.